• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU

NEUREN PHARMACEUTICALS LIMITED

3.54% ! $10.53
Market Cap $1.327B  !

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NEU
Share Price
21/04/25 15K 7.2M
21/04/25 Last post  ZacGold Comments Created with Sketch.  15K  Views Created with Sketch.  7.2M 
NEU 21/04/25 158 70K
21/04/25 Last post  Anydaynow Comments Created with Sketch.  158  Views Created with Sketch.  70K 
NEU
NEU chart
37 38 39
20/04/25 2.2K 1.2M
TRENDING NEWS

Download your free Thematic Insights report HERE

NEWS
22 Apr 2025
20/04/25 Last post  slick Comments Created with Sketch.  2.2K  Views Created with Sketch.  1.2M 
NEU
The Pill Penalty
18/04/25 0 860
18/04/25 Last post  hottod Comments Created with Sketch.  0  Views Created with Sketch.  860 
NEU
Neuren Media and Analyst Coverage
25 26 27
18/04/25 1.5K 898K
18/04/25 Last post  frogga Comments Created with Sketch.  1.5K  Views Created with Sketch.  898K 
NEU
Acadia
22 23 24
17/04/25 1.3K 706K
17/04/25 Last post  Vapor Comments Created with Sketch.  1.3K  Views Created with Sketch.  706K 
NEU 17/04/25 5 2.4K
17/04/25 Last post  ZacGold Comments Created with Sketch.  5  Views Created with Sketch.  2.4K 
NEU 16/04/25 79 31K
16/04/25 Last post  JDBL Comments Created with Sketch.  79  Views Created with Sketch.  31K 

See All Discussions arrow Created with Sketch.

Timeline

Update - Notification of buy-back - NEU
17 Apr 08:36
 
Change of Director's Interest Notice - J Basile
16 Apr 16:52
 
NEU confirms primary endpoints for Phase 3 trial in PMS
14 Apr 08:58
 
Update - Notification of buy-back - NEU
07 Apr 08:26
 
Update - Notification of buy-back - NEU
04 Apr 09:03
 
Notification of cessation of securities - NEU
03 Apr 08:21
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$10.53
Change
0.360(3.54%)
Mkt cap ! $1.327B
Open High Low Value Volume
$10.11 $10.53 $10.11 $6.973M 672.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $10.45
 

Sellers (Offers)

Price($) Vol. No.
$10.80 1000 1
View Market Depth
Last trade - 16.10pm 21/04/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.